PMC:7445716 / 79549-79875
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T656 | 116-127 | Body_part | denotes | ganglioside | http://purl.org/sig/ont/fma/fma82816 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T735 | 69-77 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T736 | 86-89 | Disease | denotes | MFS | http://purl.obolibrary.org/obo/MONDO_0007947|http://purl.obolibrary.org/obo/MONDO_0019202|http://purl.obolibrary.org/obo/MONDO_0005851 |
| T739 | 248-256 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T740 | 257-260 | Disease | denotes | MFS | http://purl.obolibrary.org/obo/MONDO_0007947|http://purl.obolibrary.org/obo/MONDO_0019202|http://purl.obolibrary.org/obo/MONDO_0005851 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T368 | 45-49 | Chemical | denotes | GD1b | http://purl.obolibrary.org/obo/CHEBI_28175 |
| T369 | 116-127 | Chemical | denotes | ganglioside | http://purl.obolibrary.org/obo/CHEBI_28892 |
| T370 | 222-226 | Chemical | denotes | GQ1b | http://purl.obolibrary.org/obo/CHEBI_27515 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1193 | 89-96 | Species | denotes | patien | Tax:9606 |
| 1194 | 115-126 | Chemical | denotes | -gangliosid | MESH:D005732 |
| 1196 | 68-76 | Disease | denotes | COVID-1 | MESH:C000657245 |
| 1197 | 85-88 | Disease | denotes | MF | MESH:D008382 |
| 1198 | 247-255 | Disease | denotes | -COVID-1 | MESH:C000657245 |
| 1199 | 256-259 | Disease | denotes | MF | MESH:D008382 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T471 | 0-326 | Sentence | denotes | Conversely, the observation of positive anti-GD1b antibodies in one COVID-19-related MFS patient and negative anti-ganglioside antibodies in other five cases appear in discordance with the high prevalence (≈ 90%) of anti-GQ1b antibodies among non-COVID-19 MFS cases [86], and may suggest different immune-mediated mechanisms. |
LitCovid-PD-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
|---|---|---|---|---|---|
| T19 | 40-49 | GlycoEpitope | denotes | anti-GD1b | http://www.glycoepitope.jp/epitopes/AN0403 |
| T20 | 45-49 | GlycoEpitope | denotes | GD1b | http://www.glycoepitope.jp/epitopes/EP0059 |
| T21 | 222-226 | GlycoEpitope | denotes | GQ1b | http://www.glycoepitope.jp/epitopes/EP0069 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1183 | 50-60 | GO:0042571 | denotes | antibodies |
| T1184 | 69-77 | SP_7 | denotes | COVID-19 |
| T1185 | 116-127 | CHEBI:16856;CHEBI:16856 | denotes | ganglioside |
| T1186 | 128-138 | GO:0042571 | denotes | antibodies |
| T1187 | 227-237 | GO:0042571 | denotes | antibodies |
| T1188 | 248-256 | SP_7 | denotes | COVID-19 |
| T1189 | 299-305 | UBERON:0002405 | denotes | immune |
| T96674 | 50-60 | GO:0042571 | denotes | antibodies |
| T22339 | 69-77 | SP_7 | denotes | COVID-19 |
| T81300 | 116-127 | CHEBI:16856;CHEBI:16856 | denotes | ganglioside |
| T21266 | 128-138 | GO:0042571 | denotes | antibodies |
| T10518 | 227-237 | GO:0042571 | denotes | antibodies |
| T64439 | 248-256 | SP_7 | denotes | COVID-19 |
| T4575 | 299-305 | UBERON:0002405 | denotes | immune |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32840686-30246056-63205867 | 267-269 | 30246056 | denotes | [8 |